Expanding Treatment Reach Neuromod is actively expanding the availability of its tinnitus treatment device across Europe through new clinical partnerships and office expansion, presenting opportunities to collaborate with healthcare providers and clinics seeking innovative tinnitus solutions.

Strategic Market Entry The recent launch of the tinnitus treatment in the Netherlands and partnerships in the US highlight Neuromod's focus on entering new markets, creating sales potential in regions with high prevalence of chronic tinnitus and increasing demand for non-invasive treatment options.

Product Education & Training The launch of the Tinnitus Masterclass online course indicates Neuromod's commitment to training healthcare professionals, opening avenues for sales of supplementary educational services or integration with clinical workflows.

Growing Workforce Neuromod's recent increase in headcount, particularly in engineering, sales, and marketing, suggests a focus on scaling operations and enhancing market engagement, providing opportunities for partnership and targeted sales efforts.

Investment & Funding Growth With recent fundraising and series B financing, Neuromod is positioned for product development and market expansion, presenting opportunities for sales collaborations around new device features or upcoming offerings in the neurostimulation space.